Microscope in Laboratory

About Us

iSTAT Therapeutics is breaking resistance to cancer immunotherapy

By eliminating the “master brake" engaged by the tumor in multiple types of immune cells,  iSTAT's novel platform of bi-modal oligonucleotide drugs overcomes a key hurdle in achieving effective immunotherapy treatments across a variety of cancer types, independently of their genetic differences.

©2018 by istattx.com. Proudly created with Wix.com